Chromatin Immunoprecipitation (ChIP) News and Research

RSS

Four UC Santa Barbara engineers named 2015 NAI fellows

Four UC Santa Barbara engineers have been elected to the National Academy of Inventors for 2015. Recognized for their "highly prolific spirit of invention," professors John Bowers, Craig Hawker, Umesh Mishra and Galen Stucky are among the newest fellows elected by the organization.

16 Dec 2015

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.

18 Nov 2015

Children in low-income families have greater access to preventive care under Medicaid, CHIP

Researchers have found that children in low-income families experience greater access to preventive medical and dental care under Medicaid or the Children's Health Insurance Program (CHIP) than children covered by private insurance. However, for all types of insurance coverage, access to pediatric specialty care was a challenge.

17 Nov 2015

MIPT researchers patent graphene biosensors that may accelerate development of novel drugs

The US Patent Office has recently published the patent application (no. US 2015/0301039), which was filed by the MIPT in May this year and is titled Biological Sensor and a Method of the Production of Biological Sensor. In Russia, this development is already protected by the patent No. 2527699 with a priority date of February 20, 2013. The key feature of the sensor is the use of a linking layer for biomolecule immobilization comprising a thin film of graphene or graphene oxide.

17 Nov 2015

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Chromatrap, a business unit of Porvair Sciences Ltd, has announced the launch of its own range of Chromatin Immunoprecipitation (ChIP)-validated antibodies.

From Chromatrap® - Porvair Sciences Ltd 9 Nov 2015

UTA developing SMART bandage system that can monitor, cure wounds in real time

The University of Texas at Arlington is developing a sensing and therapeutic tool that will help doctors and other healthcare workers better monitor and heal patients' complex wounds more quickly.

5 Nov 2015

PolyU researchers develop novel biosensor for measuring glucose level in saliva

Diabetic patients have to monitor blood glucose regularly and frequently, but conventional method of taking blood sample for measuring glucose level is painful. It is therefore important to develop high performance biological sensors for monitoring the glucose level at a reasonable cost.

3 Nov 2015

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

Academics at Loughborough University hope to boost early detection rates of cancer in developing countries with their portable lab-in-a-briefcase that can operate even at high temperatures.

31 Oct 2015

Improved results yielded from new ChIP-seq protocol

Chromatrap®, a business unit of Porvair Sciences, has developed a new protocol that further extends the many advantages of its popular Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits.

From Chromatrap® - Porvair Sciences Ltd 23 Oct 2015

Being a grandparent good for your health, says SLU geriatrician

Note to Mimi, Didi, Gigi, G-Ma and the rest of the gang who have swapped out your own pet names for Grandma: Being a grandparent is good for your health. So says Angela Sanford, M.D., assistant professor of geriatrics at Saint Louis University.

20 Oct 2015

Nanovis announces availability of new FortiCore interbody fusion devices

Nanovis, a life sciences company committed to developing scientifically advanced regenerative platforms for implantable medical devices, today announced the availability of the FortiCore wedge shaped lordotic cervical cage and a transforaminal lumbar interbody fusion (TLIF) device with increased scaffolding.

15 Oct 2015

Innovative optoelectronic implantable device helps access brain microcircuits

Brown University researchers have created a new type of optoelectronic implantable device to access brain microcircuits, synergizing a technique that enables scientists to control the activity of brains cells using pulses of light.

13 Oct 2015

Palm Beach Vapors unveils safe, fully customizable vaping technology for tobacco users

Millions of smokers worldwide have used vaping to help finally break free from the shackles of tobacco. An April 2015 study released by a team of researchers at Kings College London showed electronic cigarettes to be up to 95 percent less harmful than traditional cigarette smoking.

13 Oct 2015

Lund researchers one step closer to developing implantable electrodes for capturing brain function

For nearly nine years, researchers at Lund University have been working on developing implantable electrodes that can capture signals from single neurons in the brain over a long period of time - without causing brain tissue damage. They are now one big step closer to reaching this goal, and the results are published in the scientific journal Frontiers in Neuroscience.

8 Oct 2015

NIBIB-supported bioengineers work to reduce platelet activation and clotting in patients with VADs

A team of NIBIB-supported bioengineers, aerospace scientists, and cardiovascular clinicians are improving the function of the thousands of life-saving ventricular assist devices (VADs) implanted in advanced heart failure patients each year.

8 Oct 2015

NYIT's Aydin Farajidavar receives NIH grant to develop implantable wireless device for measuring gastric activity

New York Institute of Technology Assistant Professor Aydin Farajidavar has received a $457,000 National Institutes of Health grant to develop an implantable wireless system to study the body's gastric and digestive systems.

8 Oct 2015

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.

7 Oct 2015

New self-contained device could provide instant results to routine lab tests, accelerate treatment and diagnosis

Researchers at Houston Methodist, along with collaborators at two major Singapore institutions, have developed a lab in a needle device that could provide instant results to routine lab tests, accelerating treatment and diagnosis by days.

29 Sep 2015

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Advanced smartphone-enabled medical device technology for the rapid and cost-effective detection of infectious diseases will be featured at this year’s prestigious Medica show.

29 Sep 2015

Researchers develop chip-based instrument for reliable detection of Ebola virus

A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.

25 Sep 2015

Chromatin Immunoprecipitation (ChIP) News and Research

Four UC Santa Barbara engineers named 2015 NAI fellows

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

Children in low-income families have greater access to preventive care under Medicaid, CHIP

MIPT researchers patent graphene biosensors that may accelerate development of novel drugs

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

UTA developing SMART bandage system that can monitor, cure wounds in real time

PolyU researchers develop novel biosensor for measuring glucose level in saliva

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

Improved results yielded from new ChIP-seq protocol

Being a grandparent good for your health, says SLU geriatrician

Nanovis announces availability of new FortiCore interbody fusion devices

Innovative optoelectronic implantable device helps access brain microcircuits

Palm Beach Vapors unveils safe, fully customizable vaping technology for tobacco users

Lund researchers one step closer to developing implantable electrodes for capturing brain function

NIBIB-supported bioengineers work to reduce platelet activation and clotting in patients with VADs

NYIT's Aydin Farajidavar receives NIH grant to develop implantable wireless device for measuring gastric activity

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

New self-contained device could provide instant results to routine lab tests, accelerate treatment and diagnosis

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Researchers develop chip-based instrument for reliable detection of Ebola virus

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News